The Use of Intracoronary Sodium Nitroprusside to Treat No-Reflow after Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Background: The no-reflow phenomenon is characterized by an inadequate myocardial tissue perfusion in the presence of a patent epicardial coronary artery. The incidence of no-reflow appears to be highest in patients undergoing primary percutaneous coronary intervention (PCI) in acute myocardial infa...

Full description

Saved in:

Bibliographic Details
Published in:	Herz Vol. 35; no. 2; pp. 114 - 118
Main Authors:	Tesic, Milorad B., Stankovic, Goran, Vukcevic, Vladan, Ostojic, Miodrag C.
Format:	Journal Article
Language:	English
Published:	Munchen Urban and Vogel 01-03-2010 Springer Nature B.V
Subjects:	Angioplasty, Balloon, Coronary - methods Cardiology Coronary Angiography Coronary Artery Bypass Coronary Restenosis - diagnostic imaging Coronary Restenosis - therapy Coronary Vessels - drug effects Female Graft Occlusion, Vascular - diagnostic imaging Graft Occlusion, Vascular - therapy Humans Injections Internal Medicine Male Medicine Medicine & Public Health Middle Aged Myocardial Infarction - diagnostic imaging Myocardial Infarction - therapy Nitroprusside - administration & dosage No-Reflow Phenomenon - diagnostic imaging No-Reflow Phenomenon - drug therapy Postoperative Complications - diagnostic imaging Postoperative Complications - therapy Vasodilator Agents - administration & dosage Veins - transplantation SVG Complications Aortokoronarer Venenbypass Percutaneous coronary intervention Stent No-reflow Sodium nitroprusside No-Reflow-Phänomen Komplikation Nitroprussidnatrium PCI Perkutane koronare Intervention Stents
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!